Glucose-dependent GPER1 expression modulates tamoxifen-induced IGFBP-1 accumulation
1Department of Chemistry and Biochemistry, New Mexico State University, Las Cruces, New Mexico, USA.
Journal of Molecular Endocrinology
|June 27, 2019
Summary
Low glucose levels increase G protein-coupled estrogen receptor 1 (GPER1) expression in breast cancer cells, mediated by AMP-activated protein kinase (AMPK). This enhances tamoxifen
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- G protein-coupled estrogen receptor 1 (GPER1) mediates rapid estrogen signaling.
- GPER1's role in hormone-responsive cancers is known, but its expression regulation is unclear.
- Understanding GPER1 regulation is crucial for breast cancer therapy, including tamoxifen action.
Purpose of the Study:
- To investigate the effect of D-glucose levels on GPER1 expression in breast cancer cells.
- To determine the role of AMP-activated protein kinase (AMPK) in glucose-mediated GPER1 regulation.
- To assess if altered GPER1 expression impacts tamoxifen's efficacy in breast cancer cells.
Main Methods:
- Culturing breast cancer cells in varying D-glucose concentrations.
- Utilizing small molecule modulators and genetic manipulation of AMPK.
- Measuring GPER1 expression and tamoxifen-induced IGFBP-1 transcription.
Main Results:
- Low D-glucose significantly increased GPER1 expression in breast cancer cells.
- AMPK activation promoted GPER1 accumulation, while inhibition reduced it under low glucose.
- D-glucose deprivation enhanced GPER1-mediated tamoxifen-induced IGFBP-1 transcription.
Conclusions:
- GPER1 expression is regulated by D-glucose levels in breast cancer cells.
- AMPK is a key mediator in the glucose-dependent regulation of GPER1.
- Altered GPER1 expression due to glucose availability may influence breast cancer cell sensitivity to tamoxifen.
More Related Videos
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
3.9K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.9K
Glucose Transporters
27.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.3K
Cell Specific Gene Expression
16.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.3K
Frequency-dependent Selection
23.1K
When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
23.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
601
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
601
Glucose Absorption Into the Small Intestine
35.2K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
35.2K


